Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/21/22
End: 03/21/23
Due: 03/21/24
Phase: N/A
Priority: Normal
Start: 12/27/22
End: 12/31/23
Due: 12/31/24
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Sequential Enhanced Safety Study of a Novel Coronavirus Messenger RNA (mRNA) Vaccine in Adults Aged 18 Years and Older. | NCT05568693 | Yu Qin | user2@example.com | None | 2022-09-21 | 2023-03-21 | 2024-03-21 | - | - | 2025-07-14 |
| An Investigator Initiated, Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Immunogenicity and Efficacy of the Recombinant Two-component COVID-19 Vaccine (CHO Cell) in Adults Aged 18 Years and Older | NCT05679466 | Yu Qin | user2@example.com | None | 2022-12-27 | 2023-12-31 | 2024-12-31 | - | - | 2025-07-14 |